New treatment option for schizophrenia – Reagila(R) – listed on PBS this week

– Adults living with schizophrenia will have access to a new treatment option with Reagila(R) (cariprazine) now reimbursed on the Pharmaceutical Benefits Scheme from 1 September, 2021.1 – There continues to be a significant, unmet need in treating schizophrenia. With a complex range of symptoms,2 treatment is not a “one size fits all”.3 This listing […]